The largest database of trusted experimental protocols

13 protocols using recombinant human il 6

1

Osteosarcoma and Glioblastoma Cell Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
U2OS and MG-63 osteosarcoma cells and human normal osteoblastic hFOB 1.19 cells were obtained from the Shanghai Institute of Biochemistry and Cell Biology (Chinese Academy of Sciences, Shanghai, China). The human glioblastoma cell line, T98G, was purchased from American Type Culture Collection (Rockville, MD, USA). Dulbecco's Modified Eagle Medium (DMEM) cell culture medium and fetal bovine serum (FBS) were purchased from Hangzhou Sijiqing Biological Engineering Material Co. Ltd. (Hangzhou, Zhejiang, China). Antibodies against OPN were purchased from Abcam (Cambridge, MA). N-acetyl cysteine and recombinant human IL-6 were purchased from Sigma (St. Louis, MO, USA). Enhanced chemiluminescence (ECL) western blotting kits were obtained from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA, USA).
+ Open protocol
+ Expand
2

Modulating Cell Signaling Pathways

Check if the same lab product or an alternative is used in the 5 most similar protocols
Recombinant human IL-6 and EGF were purchased from Sigma-Aldrich (H7416 and E9644), reconstituted in phosphate-buffered saline, and used at final concentrations of 25 and 50 ng/mL, respectively. TGFβ was purchased from Sigma-Aldrich and used at a final concentration of 5 ng/mL. The MEK1/2 inhibitor PD98059 and STAT3 inhibitor S3I-201 were purchased from Calbiochem, dissolved in dimethyl sulfoxide (DMSO), and used at final concentrations of 50 μM and 100 μM, respectively. Cells were preincubated with the inhibitors for 1 h at 37°C and then incubated in the absence or presence of IL-6. The experiments ran for 4 days and media with inhibitor was changed every 2 days. BIX15 was purchased from Vibrant Pharma (Brantford, ON), dissolved in DMSO, and used at a final concentration of 5 μM. Control cells were treated with the same amount of DMSO (Vehicle).
+ Open protocol
+ Expand
3

Exploring Liver Cancer Cell Responses

Check if the same lab product or an alternative is used in the 5 most similar protocols
Bel-7404, Bel-7402, and HepG2 cells were obtained from American Type Culture
Collection (ATCC, Manassas, VA, U.S.A.) and respectively cultured in RPMI 1640
and DMEM (Invitrogen Life Technologies) with 10% FBS (Invitrogen Life
Technologies) at 37°C in a humidified atmosphere with 5%
CO2.
On reaching 60–80% confluence, both cell lines were treated with
BMSC-CM, serum-free DMEM, 2% FBS-containing DMEM, recombinant human IL-6
(Sigma–Aldrich Corp., St. Louis, MO, U.S.A.) or the anti-IL-6 antibody
(R&D Systems, Inc., Minneapolis, MN, U.S.A.).
+ Open protocol
+ Expand
4

Cytokine ELISA and Cell Signaling Assays

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cytokine enzyme-linked immunosorbent assay (ELISA) kit (Genzyme, Cambridge, MA, USA), recombinant human IL-6 at a final concentration of 50 ng/ml (Sigma-Aldrich, Milan, Italy), proteasome inhibitor MG-132 at a final concentration of 10 mM (Calbiochem; Merck Chemicals Ltd., Nottingham, UK), cycloheximide at a final concentration of 20 µg/ml (Sigma-Aldrich; Merck KGaA, Darmstadt, Germany), hydroxyurea (Sigma-Aldrich; Merck KGaA), 5-FU (Fluorouracil; Teva Pharma Italia, Milan, Italy), Nutlin-3 (Sigma-Aldrich; Merck KGaA), anti-E-cadherin (clone 32A8, Cell Signaling Technology, Inc., Danvers, MA, USA), anti-IL-6 (Sigma-Aldrich; Merck KGaA), anti-p53 (Novocastra, Laboratories, Ltd., Newcastle upon Tyne, UK), and p53 Taqman gene expression quantitative assay kit (Applied Biosystems, Foster City, CA, USA) were used in the present study.
+ Open protocol
+ Expand
5

Molecular Response of p53 Wild-Type and Deficient Cell Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
HepG2, SW1990 and LS174T cell lines were obtained from American Type Culture Collection, and the NCM460 cell line was purchased from INCELL Corporation (San Antonio, TX, USA). All the cell lines were p53 wild-type. The HCT116 p53−/− cell line was a generous gift from Professor Bert Vogelstein.
The recombinant human IL-6 (Sigma-Aldrich, Milan, Italy) was used at a final concentration of 50 ng/ml; the proteasome inhibitor MG-132 (Calbiochem, Merck, Nottingham, UK) was used at a final concentration of 10 mM; cycloheximide (Sigma-Aldrich) was used at a concentration of 20 μg/ml; hydroxyurea (Sigma-Aldrich) was used at 3.4 mM; 5-FU (Fluorouracile, Teva Pharma Italia, Milan, Italy) was used at a dose of 20 μg/ml; Nutlin-3 (Sigma-Aldrich) was used at a concentration of 5 mM.
+ Open protocol
+ Expand
6

BRD and Notch Pathway Protein Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
The following antibodies were used: anti-BRD2, BRD3 and BRD4 (Bethyl Laboratories), anti-Jagged1 and anti-α-tubulin (Santa Cruz Biotechnology), anti-phosphoY705-STAT3, total STAT3 and anti-Notch1 Val1744 (Cell Signaling Technology). HRP-conjugated secondary antibodies were purchased from Bio-Rad. Fluorochrome-conjugated secondary antibodies were obtained from Jackson Laboratories. (R)- and (S)-JQ1 were purchased from Cayman Chemicals. Recombinant human IL-6 and DAPT were purchased from Sigma.
+ Open protocol
+ Expand
7

Anti-Inflammatory Drugs and Cell Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
HepG2 and MCF10A were obtained from ATCC between 2005 and 2009. The NCM460 cell line was purchased from INCELL Corporation (San Antonio, TX, USA) in 2014. All the cell lines were p53 wild-type. C57BL/6JOlaHsd mice were used for primary mouse embryonic fibroblast (MEF) isolation. Recombinant human IL-6 (Sigma-Aldrich, Milan, Italy) was used at a final concentration of 50 ng/ml; mouse IL-6 (Sigma-Aldrich) was used at a final concentration of 40 μg/kg; aspirin (acetylsalicylic acid, Sigma-Aldrich) was used at 0.1, 0.3, 0.5, 1, 1.5 and 3 mM in cell lines, at 30 mg/kg in mice; salicylate (Sigma-Aldrich) was used at 0.5 mM; mesalazine (5-ASA, Sigma-Aldrich) was used at 1 mM.
+ Open protocol
+ Expand
8

Investigating STAT3 Signaling in IL-6 Receptor Regulation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Recombinant human sIL-6R and goat anti-IL-6 were purchased from R&D Systems. The mouse anti-STAT3, rabbit anti-phosphor-STAT3 (Tyr705) (pSTAT3), and horseradish peroxidase (HRP)-linked anti-rabbit and anti-mouse antibodies were from Cell Signaling Technology, and recombinant human IL-6 and mouse anti-IL-6R (B-R6) were from Millipore. Rabbit anti-IL-6R (C-20) was obtained from Santa Cruz Biotechnology, mouse anti-cd49b was from BD Biosciences, mouse anti-LAMP-1 (H4A3) was from the Developmental Studies Hybridoma Bank, and NT was from Sigma. The murine monoclonal anti-SorLA (31 (link)) and the rabbit polyclonal anti-SorLA have previously been described (32 (link)). Secondary antibodies conjugated with Alexa Fluor dyes were all from Invitrogen.
+ Open protocol
+ Expand
9

Antibody Immunoblotting Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
The following antibodies were used in this study: anti-SULF2, anti-IL-6, and anti-β-catenin from Santa Cruz Biotechnology (Santa Cruz, CA, USA); anti-Bcl-XL, anti-STAT3, and anti-phospho-STAT3 from Cell signaling Technology (Danvers, MA, USA); anti-β-actin from Sigma-Aldrich (St. Louis, MO, USA). Recombinant human IL-6 was purchased from Millipore (Bedford, MA, USA).
+ Open protocol
+ Expand
10

Antibody-Based Protein Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
The following antibodies were used in the present study: anti-SOD2 from Enzo Life Sciences (Farmingdale, NY, USA); anti-IL-6 and anti-β-catenin from Santa Cruz Biotechnology (Santa Cruz, CA, USA); anti-Bcl-XL, anti-STAT3, anti-Src, and anti-phospho-Src from Cell Signaling Technology (Danvers, MA, USA); and anti-β-actin from Sigma-Aldrich (St. Louis, MO, USA). Recombinant human IL-6 was purchased from Millipore (Darmstadt, Germany).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!